PIA1/A2 polymorphism of the platelet glycoprotein receptor IIb/IIIIa and its correlation with myocardial infarction: An appraisal

Clinical and Applied Thrombosis/Hemostasis

Volumn 12, Issue 1, 2006, Pages 93-95

  Wiwanitkit, Viroj ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Myocardial infarction; Olymorphism; Platelet glycoprotein

Indexed keywords

ABCIXIMAB; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; VON WILLEBRAND FACTOR;

ALLELE; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ETHNOLOGY; GENE FREQUENCY; HEART INFARCTION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT;

CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; GENE FREQUENCY; HUMANS; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 32344438547     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960601200115     Document Type: Article

References (14)

1. Wagner KR, Giles WH, Johnson CJ, et al. Platelet glycoprotein receptor IIIIa polymorphism P1A2 and ischemic stroke risk: The Stroke Prevention in Young Women Study. Stroke 1998;29:581.
2. Rossi ML, Merlini PA. Role of GP IIb/IIIa blockers in clinical cardiology. Recent Prog Med 2003;94:440.
3. Sakariassen KS, Barstad RM. Mechanisms of thromboembolism at arterial Plaques. Thromb Res 2002;108:63.
4. Kereiakes DJ. Preferential benefit of PIAtelet glycoprotein IIb/IIIIa receptor blockade: Specific considerations by device and disease state. Am J Cardiol 1998;81:49E.
5. Curtin R. Intravenous glycoprotein IIb/IIIa antagonists: Their benefits, problems and future developments. Curr Pharm Des 2004;10:1577.
6. van Goor ML, Gomez Garcia E, Brouwers GJ, et al. PIA1/A2 polymorphism of the Platelet glycoprotein receptor IIb/IIIIa in young patients with cryptogenic TIA or ischemic stroke. Thromb Res 2002;108:63.
7. Wagner KR, Giles WH, Johnson CJ, et al. Platelet glycoprotein receptor IIIIa polymorphism P1A2 and ischemic stroke risk: The Stroke Prevention in Young Women Study. Stroke 1998;29:581.
8. Anderson JL, King GJ, Bair TL, et al. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol 1999;33:727.
9. Mikkelsson J, Perola M, Laippala P, et al. Glycoprotein IIIa P1(A1/A2) polymorphism and sudden cardiac death. J Am Coll Cardiol 2000;36:1317.
10. Carter AM, Ossei-Gerning N, Wilson IJ, Grant PJ. Association of the platelet P1(A) polymorphism of glycoprotein IIb/IIIa and the fibrinogen Bbeta 448 polymorphism with myocardial infarction and extent of coronary artery disease. Circulation 1997;96:1424.
11. Ridker PM, Hennekens CH, Schmitz C, et al. PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997;349:385.
12. Grove EL, Orntoft TF, Lassen JF, et al. The platelet polymorphism P1A2 is a genetic risk factor for myocardial infarction. J Intern Med 2004;255:637.
13. Melus V, Pullmann R, Hybenova J, et al. Is PLA1/A2 gene polymorphism of platelet membrane glycoprotein IIIa a risk factor for myocardial infarct? Bratisl Lek Listy 1999;100:593.
14. Benze G, Heinrich J, Schulte H, et al. Association of the GPIa C807T and GPIIIa P1A1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J 2002;23:325.